Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical (DE:TEV)
FRANKFURT:TEV
Teva Pharmaceutical (TEV) Stock Price & Analysis
6 Followers
TEV Stock Chart & Stats
Day’s Range€12.15 - €12.5
52-Week Range― - ―
Previous Close€12.65
Volume3.70K
Average Volume (3M)N/A
Market Cap
$13.98B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 08, 2024EPS Estimate
€0.49Last Dividend Ex-Date
Nov 27, 2017Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€14.80Price Target Upside21.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Teva Pharmaceutical News
PremiumCompany Announcements
Teva Pharmaceutical Revamps Financial Reporting Structure
Options Prices
Currently, No data available
---
Ownership Overview
0.83% Insiders
14.72% Mutual Funds
2.78% Other Institutional Investors
81.67% Public Companies and
Individual Investors
TEV FAQ
What was Teva Pharmaceutical’s price range in the past 12 months?
Currently, no data Available
What is Teva Pharmaceutical’s market cap?
Currently, no data Available
When is Teva Pharmaceutical’s upcoming earnings report date?
Teva Pharmaceutical’s upcoming earnings report date is May 08, 2024 which is in 12 days.
How were Teva Pharmaceutical’s earnings last quarter?
Teva Pharmaceutical released its earnings results on Jan 31, 2024. The company reported €0.942 earnings per share for the quarter, beating the consensus estimate of €0.723 by €0.219.
Is Teva Pharmaceutical overvalued?
According to Wall Street analysts Teva Pharmaceutical’s price is currently Undervalued.
Does Teva Pharmaceutical pay dividends?
Teva Pharmaceutical pays a Quarterly dividend of €0.07 which represents an annual dividend yield of N/A. See more information on Teva Pharmaceutical dividends here
What is Teva Pharmaceutical’s EPS estimate?
Teva Pharmaceutical’s EPS estimate is €0.49.
How many shares outstanding does Teva Pharmaceutical have?
Currently, no data Available
What happened to Teva Pharmaceutical’s price movement after its last earnings report?
Teva Pharmaceutical reported an EPS of €0.942 in its last earnings report, beating expectations of €0.723. Following the earnings report the stock price went up 7.042%.
Which hedge fund is a major shareholder of Teva Pharmaceutical?
Among the largest hedge funds holding Teva Pharmaceutical’s share is Slate Path Capital LP. It holds Teva Pharmaceutical’s shares valued at 274M.
---
Teva Pharmaceutical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€14.80 (21.79% Upside)
€14.80 (21.79% Upside)
Blogger Sentiment
Bullish
DE:TEV Sentiment 80%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $4.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
59.58%
12-Months-Change
Fundamentals
Return on Equity
-6.84%
Trailing 12-Months
Asset Growth
-1.20%
Trailing 12-Months
Company Description
Teva Pharmaceutical
Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.
---
TEV Company Deck
---
TEV Earnings Call
Q4 2024
0:00 / 0:00
---
TEV Revenue Breakdown
54.45% North America
32.42% Europe
13.12% International Markets
---
TEV Stock 12 Months Forecast
Average Price Target
€14.80
▲(21.79% Upside)
Technical Analysis
Best Analysts Covering TEV
1 Year
1 Year Success Rate
10/16 ratings generated profit
1 Year Average Return
+15.42%
assigned a buy rating 21 days ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +15.42% per trade.
---